Stock Market & Financial Investment News

News Breaks September 5, 2012 05:26 EDT NVS Novartis new Lucentis data confirms long-term efficacy and safety profile New data for Lucentis, or ranibizumab, the only anti-VEGF therapy licensed across three ocular indications, show that individualized treatment with Lucentis provides sustained improvement in vision with a low number of injections. It is estimated that over 80% of visual impairment is preventable when due to conditions such as wet age-related macular degeneration, or wet AMD, diabetic macular edema, or DME, and visual impairment due to macular edema secondary to retinal vein occlusion, or RVO. These conditions can eventually lead to blindness if left untreated. Lucentis also demonstrated benefits in visual acuity outcomes in patients with visual impairment due to choroidal neovascularization, or CNV, secondary to pathological myopia, or PM. Lucentis is currently not approved to treat this condition. Novartis will submit for regulatory approval in this indication in the European Union in the third quarter of this year and in Japan by the end of 2012. News For NVS From The Last 14 Days Check below for free stories on NVS the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2013 07:44 EDT NVS Sachs Associates to host a forum Subscribe for More Information 07:24 EDT NVS Global Health Care to host a conference Subscribe for More Information May 20, 2013 07:29 EDT NVS Deutsche Bank to host a conference dbAccess Asia Conference 2013 is being held in Singapore on May 20-22. May 17, 2013 16:20 EDT NVS Novartis drug Afinitor extended time without disease progression in women Subscribe for More Information May 16, 2013 08:11 EDT NVS Novartis says no intention of pursuing Actavis, Bloomberg reports Subscribe for More Information May 15, 2013 19:37 EDT NVS Novartis weighing Actavis bid, WSJ reports Subscribe for More Information 18:17 EDT NVS Novartis weighs possible bid for Actavis, DJ reports Subscribe for More Information May 10, 2013 05:42 EDT NVS Novartis drug Ilaris approved by FDA Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.